{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:14:18Z","timestamp":1793042058267,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>To investigate the predictive value of the quantitative T2-FLAIR mismatch ratio (qT2FM) with fully automated tumor segmentation in adult-type diffuse lower-grade gliomas (LGGs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>This retrospective study included 218 consecutive patients (mean age, 47 years\u2009\u00b1\u200915 [SD]; 125 males) diagnosed with adult-type diffuse LGG. The cohort was classified into IDH wild-type (IDHwt), IDH-mutant with 1p\/19q-codeletion (IDHmut-Codel), and IDH-mutant without 1p\/19q-codeletion (IDHmut-Noncodel) subtypes. Tumor masks were obtained using deep learning-based segmentation, and qT2FM was calculated from the differences in signal intensity ratios on T2 and FLAIR images. Multivariable logistic regression identified predictors for identifying IDHmut-Noncodel and IDH mutation status. Point-biserial correlations were analyzed between qualitative and quantitative T2FM, and median apparent diffusion coefficient (ADC) value. Diagnostic performance was evaluated with a receiver operating characteristic curve.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The IDHmut-Noncodel group had a higher qT2FM (0.37\u2009\u00b1\u20090.38, <jats:italic>p<\/jats:italic>\u2009=\u20090.004) than the IDHmut-Codel (0.24\u2009\u00b1\u20090.39) and IDHwt groups (0.07\u2009\u00b1\u20090.62). The qT2FM was the only independent imaging predictor for identifying IDHmut-Noncodel (OR\u2009=\u20093.43, 95% CI: 1.30\u20139.05, <jats:italic>p<\/jats:italic>\u2009=\u20090.01). Independent predictors of IDH mutation were younger age (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), frontal lobe location (<jats:italic>p<\/jats:italic>\u2009=\u20090.007), cortical involvement (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and higher qT2FM (<jats:italic>p<\/jats:italic>\u2009=\u20090.034). The qT2FM significantly correlated with visual T2FM (vT2FM) and median ADC value. Adding qT2FM to vT2FM improved performance in identifying IDHmut-Noncodel (AUC 0.77, 95% CI: 0.70\u20130.82) and IDH mutation status (AUC 0.77, 95% CI: 0.71\u20130.83) than each parameter alone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The qT2FM ratio, derived from deep learning-based tumor segmentation, is a valuable predictor for identifying IDH mutation status and the IDHmut-Noncodel subtype in patients with adult-type diffuse LGG.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Question<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>Does deep-learning-based quantification of the T2-FLAIR mismatch sign provide accurate prediction of IDH-mutant, 1p\/19q non-codeleted astrocytomas and enhance identification of IDH mutation status<\/jats:italic>?<\/jats:p>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Findings<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>Quantifying the T2-FLAIR mismatch sign with a fully automated segmentation tool achieved high accuracy in identifying IDH-mutant, 1p\/19q non-codeleted astrocytomas, and enhanced IDH status prediction<\/jats:italic>.<\/jats:p>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Clinical relevance<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>Integrating the qT2FM into clinical protocols enhances diagnostic precision and guides treatment strategies, underscoring the role of advanced imaging in neuro-oncology<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00330-025-11475-7","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T20:39:03Z","timestamp":1741293543000},"page":"5193-5202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Deep learning-based quantification of T2-FLAIR mismatch sign: extending IDH mutation prediction in adult-type diffuse lower-grade glioma"],"prefix":"10.1007","volume":"35","author":[{"given":"Young Hun","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5175-3307","authenticated-orcid":false,"given":"Kyu Sung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Yun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Ye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehyuk","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inpyeong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roh-Eul","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koung Mi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Jin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Ho","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"11475_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1148\/radiol.2020191832","volume":"296","author":"J Maynard","year":"2020","unstructured":"Maynard J, Okuchi S, Wastling S et al (2020) World Health Organization Grade II\/III glioma molecular status: prediction by MRI morphologic features and apparent diffusion coefficient. Radiology 296:111\u2013121","journal-title":"Radiology"},{"key":"11475_CR2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/neuonc\/noac031","volume":"24","author":"J Jo","year":"2022","unstructured":"Jo J, van den Bent MJ, Nabors B, Wen PY, Schiff D (2022) Surveillance imaging frequency in adult patients with lower-grade (WHO grade 2 and 3) gliomas. Neuro Oncol 24:1035\u20131047","journal-title":"Neuro Oncol"},{"key":"11475_CR3","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Brat DJ, Verhaak RG, Aldape KD et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481\u20132498","journal-title":"N Engl J Med"},{"key":"11475_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251","journal-title":"Neuro Oncol"},{"key":"11475_CR5","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.1158\/1078-0432.CCR-17-0560","volume":"23","author":"SH Patel","year":"2017","unstructured":"Patel SH, Poisson LM, Brat DJ et al (2017) T2-FLAIR mismatch, an imaging biomarker for IDH and 1p\/19q status in lower-grade gliomas: a TCGA\/TCIA project. Clin Cancer Res 23:6078\u20136085","journal-title":"Clin Cancer Res"},{"key":"11475_CR6","first-page":"vdaa004","volume":"2","author":"M Foltyn","year":"2020","unstructured":"Foltyn M, Nieto Taborda KN, Neuberger U et al (2020) T2\/FLAIR-mismatch sign for noninvasive detection of IDH-mutant 1p\/19q non-codeleted gliomas: validity and pathophysiology. Neurooncol Adv 2:vdaa004","journal-title":"Neurooncol Adv"},{"key":"11475_CR7","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1007\/s00330-020-07467-4","volume":"31","author":"SI Park","year":"2021","unstructured":"Park SI, Suh CH, Guenette JP, Huang RY, Kim HS (2021) The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p\/19q-noncodeleted lower-grade gliomas: a systematic review and diagnostic meta-analysis. Eur Radiol 31:5289\u20135299","journal-title":"Eur Radiol"},{"key":"11475_CR8","doi-asserted-by":"publisher","first-page":"e1582","DOI":"10.1212\/WNL.0000000000010324","volume":"95","author":"P Throckmorton","year":"2020","unstructured":"Throckmorton P, Graber JJ (2020) T2-FLAIR mismatch in isocitrate dehydrogenase mutant astrocytomas: variability and evolution. Neurology 95:e1582\u2013e1589","journal-title":"Neurology"},{"key":"11475_CR9","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1007\/s00330-021-08500-w","volume":"32","author":"M Li","year":"2022","unstructured":"Li M, Ren X, Chen X et al (2022) Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p\/19q non-codeleted lower-grade glioma. Eur Radiol 32:3869\u20133879","journal-title":"Eur Radiol"},{"key":"11475_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00234-024-03297-z","volume":"66","author":"P Malik","year":"2024","unstructured":"Malik P, Soliman R, Chen YA et al (2024) Patterns of T2-FLAIR discordance across a cohort of adult-type diffuse gliomas and deviations from the classic T2-FLAIR mismatch sign. Neuroradiology 66:521\u2013530","journal-title":"Neuroradiology"},{"key":"11475_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/neuonc\/noac166","volume":"25","author":"SR van der Voort","year":"2023","unstructured":"van der Voort SR, Incekara F, Wijnenga MMJ et al (2023) Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning. Neuro Oncol 25:279\u2013289","journal-title":"Neuro Oncol"},{"key":"11475_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/neuros\/nyab103","volume":"89","author":"A Jian","year":"2021","unstructured":"Jian A, Jang K, Manuguerra M, Liu S, Magnussen J, Di Ieva A (2021) Machine learning for the prediction of molecular markers in glioma on magnetic resonance imaging: a systematic review and meta-analysis. Neurosurgery 89:31\u201344","journal-title":"Neurosurgery"},{"key":"11475_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00234-024-03288-0","volume":"66","author":"K Kikuchi","year":"2024","unstructured":"Kikuchi K, Togao O, Yamashita K et al (2024) Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p\/19q-codeleted. Neuroradiology 66:333\u2013341","journal-title":"Neuroradiology"},{"key":"11475_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3174\/ajnr.A8094","volume":"45","author":"NS Cho","year":"2024","unstructured":"Cho NS, Sanvito F, Le VL et al (2024) Quantification of T2-FLAIR mismatch in nonenhancing diffuse gliomas using digital subtraction. AJNR Am J Neuroradiol 45:188\u2013197","journal-title":"AJNR Am J Neuroradiol"},{"key":"11475_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3174\/ajnr.A7341","volume":"43","author":"S Mohammed","year":"2022","unstructured":"Mohammed S, Ravikumar V, Warner E et al (2022) Quantifying T2-FLAIR mismatch using geographically weighted regression and predicting molecular status in lower-grade gliomas. AJNR Am J Neuroradiol 43:33\u201339","journal-title":"AJNR Am J Neuroradiol"},{"key":"11475_CR16","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1002\/hbm.24750","volume":"40","author":"F Isensee","year":"2019","unstructured":"Isensee F, Schell M, Pflueger I et al (2019) Automated brain extraction of multisequence MRI using artificial neural networks. Human Brain Mapp 40:4952\u20134964","journal-title":"Human Brain Mapp"},{"key":"11475_CR17","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S1470-2045(19)30098-1","volume":"20","author":"P Kickingereder","year":"2019","unstructured":"Kickingereder P, Isensee F, Tursunova I et al (2019) Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study. Lancet Oncol 20:728\u2013740","journal-title":"Lancet Oncol"},{"key":"11475_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1109\/42.906424","volume":"20","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20:45\u201357","journal-title":"IEEE Trans Med Imaging"},{"key":"11475_CR19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00234-023-03196-9","volume":"65","author":"MD Lee","year":"2023","unstructured":"Lee MD, Patel SH, Mohan S et al (2023) Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium. Neuroradiology 65:1343\u20131352","journal-title":"Neuroradiology"},{"key":"11475_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00330-019-06395-2","volume":"30","author":"MK Lee","year":"2020","unstructured":"Lee MK, Park JE, Jo Y, Park SY, Kim SJ, Kim HS (2020) Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2\/FLAIR mismatch sign. Eur Radiol 30:844\u2013854","journal-title":"Eur Radiol"},{"key":"11475_CR21","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/neuonc\/noaa041","volume":"22","author":"R Jain","year":"2020","unstructured":"Jain R, Johnson DR, Patel SH et al (2020) \u201cReal world\u201d use of a highly reliable imaging sign: \u201cT2-FLAIR mismatch\u201d for identification of IDH mutant astrocytomas. Neuro Oncol 22:936\u2013943","journal-title":"Neuro Oncol"},{"key":"11475_CR22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11060-021-03720-y","volume":"152","author":"SH Patel","year":"2021","unstructured":"Patel SH, Batchala PP, Muttikkal TJE et al (2021) Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma. J Neurooncol 152:523\u2013531","journal-title":"J Neurooncol"},{"key":"11475_CR23","doi-asserted-by":"publisher","first-page":"596448","DOI":"10.3389\/fonc.2020.596448","volume":"10","author":"M Kinoshita","year":"2020","unstructured":"Kinoshita M, Arita H, Takahashi M et al (2020) Impact of inversion time for FLAIR acquisition on the T2-FLAIR mismatch detectability for IDH-mutant, non-CODEL astrocytomas. Front Oncol 10:596448","journal-title":"Front Oncol"},{"key":"11475_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11060-020-03611-8","volume":"149","author":"E Aliotta","year":"2020","unstructured":"Aliotta E, Dutta SW, Feng X et al (2020) Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch sign. J Neurooncol 149:325\u2013335","journal-title":"J Neurooncol"},{"key":"11475_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67244-7","volume":"10","author":"S Deguchi","year":"2020","unstructured":"Deguchi S, Oishi T, Mitsuya K et al (2020) Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas. Sci Rep 10:10113","journal-title":"Sci Rep"},{"key":"11475_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10014-022-00433-6","volume":"39","author":"S Yamashita","year":"2022","unstructured":"Yamashita S, Takeshima H, Kadota Y et al (2022) T2-fluid-attenuated inversion recovery mismatch sign in lower grade gliomas: correlation with pathological and molecular findings. Brain Tumor Pathol 39:88\u201398","journal-title":"Brain Tumor Pathol"},{"key":"11475_CR27","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1016\/j.wneu.2021.02.042","volume":"149","author":"Y Fujita","year":"2021","unstructured":"Fujita Y, Nagashima H, Tanaka K et al (2021) The histopathologic and radiologic features of T2-FLAIR mismatch sign in IDH-mutant 1p\/19q non-codeleted astrocytomas. World Neurosurg 149:e253\u2013e260","journal-title":"World Neurosurg"},{"key":"11475_CR28","first-page":"vdac010","volume":"4","author":"YA Do","year":"2022","unstructured":"Do YA, Cho SJ, Choi BS et al (2022) Predictive accuracy of T2-FLAIR mismatch sign for the IDH-mutant, 1p\/19q noncodeleted low-grade glioma: an updated systematic review and meta-analysis. Neurooncol Adv 4:vdac010","journal-title":"Neurooncol Adv"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11475-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:35:22Z","timestamp":1757144122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11475-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["11475"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11475-7","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Seung Hong Choi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"J.Y.L. is a member of the scientific editorial board (section: head and neck) and R.E.Y. is a deputy editor for EuropeanRadiology. As such they have not participated in the selection nor review processes for this article. The remaining authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was approved by the Institutional Review Board of Seoul National University Hospital (IRB no.: 2212-077-1385).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None of the study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}